The therapeutic potential of targeting adhesion molecules in rheumatoid arthritis.
Haskard
D O
DO
Department of Medicine (Rheumatology Unit), Royal Postgraduate Medical School, Hammersmith Hospital, London.
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000276:immunology / Q000503:physiopathology / Q000628:therapy*; D015815:Cell Adhesion Molecules / Q000502:physiology*; D002465:Cell Movement; D006801:Humans; D007249:Inflammation / Q000517:prevention & control; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000502:physiology; D013601:T-Lymphocytes / Q000276:immunology
D000911:Antibodies, Monoclonal; D015815:Cell Adhesion Molecules